Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
AssigneeSyntro Corporation
InventorMark D. Cochran
Life of this patent
Estimating the term…
Abstract
The present invention provides an attenuated, genetically-engineered pseudorabies virus designated S-PRV-155 (ATCC Accession No. VR 2311). A vaccine is provided which comprises an effective immunizing amount of S-PRV-155 and a suitable carrier. A method of immunizing an animal against disease caused by pseudorabies virus is also provided which comprises administering to the animal an effective immunizing dose of the vaccine. The present invention also provides a method for distinguishing an animal vaccinated with the vaccine of the present invention from an animal infected with a naturally-occurring, wild-type pseudorabies virus.
Claims12
A vaccine which comprises an effective immunizing amount of an attenuated, genetically-engineered pseudorabies virus designated S-PRV-155 (ATCC Accession No. VR 2311) and a suitable carrier.
Dependencies are inferred from the claim text.